跳至主要内容
临床试验/NCT05863702
NCT05863702已完成不适用

Staying Healthy With Follow-up Care: A Feasibility Study Utilizing a Chatbot (Penny) Via Mobile Phones to Increase Compliance With Risk Based Survivorship Care (RBSC) Among Adult Survivors of Pediatric and Young Adult Cancers

Abramson Cancer Center at Penn Medicine2 个研究点 分布在 1 个国家目标入组 53 人开始时间: 2023年9月11日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
53
试验地点
2
主要终点
To evaluate the utilization of a chatbot (Penny) to increase receipt of evidence-based survivorship care in YA survivors of pediatric and YA cancers

研究概览

简要总结

The purpose of this project is to identify effective strategies to assist survivors of childhood and young adult cancers (diagnosed between birth and age 39) who have not returned for follow-up cancer care for 3 or more years, to reengage with the health care system. The investigator will evaluate the effect of a novel, bidirectional conversational agent ("Penny"), compared to usual care, to assist patients with scheduling appointments, lab work as well as scans and specialty appointments as needed.

详细描述

To achieve this, the investigator will use a two-arm randomized controlled trial to explore how multilevel factors impact the acceptability and effectiveness of this strategy by collecting qualitative and quantitative data from patients. Penny is a conversational agent ("chatbot") that engages patients in real time via text messaging, allowing for bidirectional communication and motivational cues to promote adherence. The chatbot will assist patients who have not been see for cancer follow-up care, with scheduling follow-up appointments, labs, scans, specialty appointments, and monitor compliance with the appointments made.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patient (age > 18 years), male or female, diagnosed with cancer as a child or as a young adult, between birth and 39 years of age
  • Patient possession of a mobile device that can receive SMS texts
  • Ability to respond to questions and engage with "Penny" in English
  • Ability to provide informed consent to participate in the study
  • Approval of the patient's oncology care team for the patient to be involved in the study

排除标准

  • Anyone who does not meet the inclusion criteria
  • Patients with a history of thyroid cancer or skin cancers

结局指标

主要结局

To evaluate the utilization of a chatbot (Penny) to increase receipt of evidence-based survivorship care in YA survivors of pediatric and YA cancers

时间窗: 1 year

We will identify adult survivors of pediatric and YA cancers who have not been seen for follow-up care \>3 years and evaluate patients' engagement with Penny to schedule return appointments and adhere to recommended life-long ongoing follow-up care according to the NCCN guidelines. Patients will be monitored over a 16-week period to see if they scheduled a follow-up care appointment.

Number of patients who agree to use Penny and patient engagement overtime in those patients randomized to the Penny arm

时间窗: 1 year

Percentage of initial responses to the conversation initiated by Penny (opt in vs. opt out) providing permission for text messaging

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Staying Healthy With Follow-up Care: A Mobile... | 临床试验